BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 26988939)

  • 1. Molecular characterization of a novel androgen receptor transgene responsive to MicroRNA mediated post-transcriptional control exerted via 3'-untranslated region.
    Ebron JS; Shukla GC
    Prostate; 2016 Jun; 76(9):834-44. PubMed ID: 26988939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of miR-30b-3p and miR-30d-5p as direct regulators of androgen receptor signaling in prostate cancer by complementary functional microRNA library screening.
    Kumar B; Khaleghzadegan S; Mears B; Hatano K; Kudrolli TA; Chowdhury WH; Yeater DB; Ewing CM; Luo J; Isaacs WB; Marchionni L; Lupold SE
    Oncotarget; 2016 Nov; 7(45):72593-72607. PubMed ID: 27683042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ARF represses androgen receptor transactivation in prostate cancer.
    Lu W; Xie Y; Ma Y; Matusik RJ; Chen Z
    Mol Endocrinol; 2013 Apr; 27(4):635-48. PubMed ID: 23449888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of miR-34b and androgen receptor pathway regulate prostate cancer aggressiveness between African-Americans and Caucasians.
    Shiina M; Hashimoto Y; Kato T; Yamamura S; Tanaka Y; Majid S; Saini S; Varahram S; Kulkarni P; Dasgupta P; Mitsui Y; Sumida M; Tabatabai L; Deng G; Kumar D; Dahiya R
    Oncotarget; 2017 Jan; 8(5):8356-8368. PubMed ID: 28039468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androgen receptor and MYC transcriptomes are equilibrated in multilayer regulatory circuitries in prostate cancer.
    Fu B; Wang L; Jia T; Wei Z; Nama N; Liang J; Liao X; Liu X; Gao Y; Liu X; Mao RS; Wang K; Guo J; Chen SS
    Prostate; 2023 Nov; 83(15):1415-1429. PubMed ID: 37565264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-1207-3p regulates the androgen receptor in prostate cancer via FNDC1/fibronectin.
    Das DK; Naidoo M; Ilboudo A; Park JY; Ali T; Krampis K; Robinson BD; Osborne JR; Ogunwobi OO
    Exp Cell Res; 2016 Nov; 348(2):190-200. PubMed ID: 27693493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell- and gene-specific regulation of primary target genes by the androgen receptor.
    Bolton EC; So AY; Chaivorapol C; Haqq CM; Li H; Yamamoto KR
    Genes Dev; 2007 Aug; 21(16):2005-17. PubMed ID: 17699749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Putative Prostate Cancer Risk SNP in an Androgen Receptor-Binding Site of the Melanophilin Gene Illustrates Enrichment of Risk SNPs in Androgen Receptor Target Sites.
    Bu H; Narisu N; Schlick B; Rainer J; Manke T; Schäfer G; Pasqualini L; Chines P; Schweiger MR; Fuchsberger C; Klocker H
    Hum Mutat; 2016 Jan; 37(1):52-64. PubMed ID: 26411452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An integrated ceRNA network identifies miR-375 as an upregulated miRNA playing a tumor suppressive role in aggressive prostate cancer.
    Chen M; Zou C; Tian Y; Li W; Li Y; Zhang D
    Oncogene; 2024 May; 43(21):1594-1607. PubMed ID: 38565944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Micro-ribonucleic Acid 494 regulation of protein S expression.
    Tay JW; Romeo G; Hughes QW; Baker RI
    J Thromb Haemost; 2013 Aug; 11(8):1547-55. PubMed ID: 23789915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Insights on the Role of Epigenetics in Androgen Receptor's Expression in Prostate Cancer.
    Camilo V; Pacheco MB; Moreira-Silva F; Outeiro-Pinho G; Gaspar VM; Mano JF; Marques CJ; Henrique R; Jerónimo C
    Biomolecules; 2023 Oct; 13(10):. PubMed ID: 37892208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The RNA-binding protein hnRNPA2 regulates β-catenin protein expression and is overexpressed in prostate cancer.
    Stockley J; Villasevil ME; Nixon C; Ahmad I; Leung HY; Rajan P
    RNA Biol; 2014; 11(6):755-65. PubMed ID: 24823909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-Wide 3'-UTR Single Nucleotide Polymorphism Association Study Identifies Significant Prostate Cancer Risk-Associated Functional Loci at 8p21.2 in Chinese Population.
    Zhang N; Huang D; Jiang G; Chen S; Ruan X; Chen H; Huang J; Liu A; Zhang W; Lin X; Wu Y; Zhang Q; Li J; Tsu JH; Wei GH; Na R
    Adv Sci (Weinh); 2022 Aug; 9(23):e2201420. PubMed ID: 35968571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulating Androgen Receptor Function in Prostate Cancer: Exploring the Diversity of Post-Translational Modifications.
    Lumahan LEV; Arif M; Whitener AE; Yi P
    Cells; 2024 Jan; 13(2):. PubMed ID: 38275816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNAs miR-186 and miR-150 down-regulate expression of the pro-apoptotic purinergic P2X7 receptor by activation of instability sites at the 3'-untranslated region of the gene that decrease steady-state levels of the transcript.
    Zhou L; Qi X; Potashkin JA; Abdul-Karim FW; Gorodeski GI
    J Biol Chem; 2008 Oct; 283(42):28274-86. PubMed ID: 18682393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Large-Scale Analysis of Genetic Variants within Putative miRNA Binding Sites in Prostate Cancer.
    Stegeman S; Amankwah E; Klein K; O'Mara TA; Kim D; Lin HY; Permuth-Wey J; Sellers TA; Srinivasan S; Eeles R; Easton D; Kote-Jarai Z; Amin Al Olama A; Benlloch S; Muir K; Giles GG; Wiklund F; Gronberg H; Haiman CA; Schleutker J; Nordestgaard BG; Travis RC; Neal D; Pharoah P; Khaw KT; Stanford JL; Blot WJ; Thibodeau S; Maier C; Kibel AS; Cybulski C; Cannon-Albright L; Brenner H; Kaneva R; Teixeira MR; ; ; Spurdle AB; Clements JA; Park JY; Batra J
    Cancer Discov; 2015 Apr; 5(4):368-79. PubMed ID: 25691096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic and oncogenic regulation of SLC16A7 (MCT2) results in protein over-expression, impacting on signalling and cellular phenotypes in prostate cancer.
    Pertega-Gomes N; Vizcaino JR; Felisbino S; Warren AY; Shaw G; Kay J; Whitaker H; Lynch AG; Fryer L; Neal DE; Massie CE
    Oncotarget; 2015 Aug; 6(25):21675-84. PubMed ID: 26035357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autonomous action and cooperativity between the ONECUT2 transcription factor and its 3' untranslated region.
    Steadman K; You S; Srinivas DV; Mouakkad L; Yan Y; Kim M; Venugopal SV; Tanaka H; Freeman MR
    Front Cell Dev Biol; 2023; 11():1206259. PubMed ID: 37484909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the MicroRNA Passenger Strand for Regulating Therapeutic Transgenes.
    Kim SJ; Lee CH; Lee SW
    Nucleic Acid Ther; 2015 Aug; 25(4):209-18. PubMed ID: 26076094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A high-throughput 3' UTR reporter screening identifies microRNA interactomes of cancer genes.
    Van Peer G; Mets E; Claeys S; De Punt I; Lefever S; Ongenaert M; Rondou P; Speleman F; Mestdagh P; Vandesompele J
    PLoS One; 2018; 13(3):e0194017. PubMed ID: 29522551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.